392 related articles for article (PubMed ID: 20089648)
21. B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.
Viner KM; Girgis N; Kwak H; Isaacs SN
Virology; 2007 May; 361(2):356-63. PubMed ID: 17188733
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of human dendritic cells by wild-type and M protein mutant vesicular stomatitis viruses engineered to express bacterial flagellin.
Ahmed M; Puckett S; Arimilli S; Braxton CL; Mizel SB; Lyles DS
J Virol; 2010 Nov; 84(22):12093-8. PubMed ID: 20844045
[TBL] [Abstract][Full Text] [Related]
23. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
McCurdy LH; Rutigliano JA; Johnson TR; Chen M; Graham BS
J Virol; 2004 Nov; 78(22):12471-9. PubMed ID: 15507634
[TBL] [Abstract][Full Text] [Related]
24. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.
Hooper JW; Custer DM; Thompson E
Virology; 2003 Feb; 306(1):181-95. PubMed ID: 12620810
[TBL] [Abstract][Full Text] [Related]
25. Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
Binjawadagi B; Ma Y; Binjawadagi R; Brakel K; Harder O; Peeples M; Li J; Niewiesk S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408176
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.
Locher S; Schweneker M; Hausmann J; Zimmer G
J Gen Virol; 2018 Jul; 99(7):866-879. PubMed ID: 29869979
[TBL] [Abstract][Full Text] [Related]
27. Recombinant adenovirus expressing vesicular stomatitis virus G proteins induce both humoral and cell-mediated immune responses in mice and goats.
Xue X; Yu Z; Jin H; Liang L; Li J; Li X; Wang Y; Cui S; Li G
BMC Vet Res; 2021 Jan; 17(1):36. PubMed ID: 33461549
[TBL] [Abstract][Full Text] [Related]
28. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.
Case JB; Rothlauf PW; Chen RE; Kafai NM; Fox JM; Smith BK; Shrihari S; McCune BT; Harvey IB; Keeler SP; Bloyet LM; Zhao H; Ma M; Adams LJ; Winkler ES; Holtzman MJ; Fremont DH; Whelan SPJ; Diamond MS
Cell Host Microbe; 2020 Sep; 28(3):465-474.e4. PubMed ID: 32798445
[TBL] [Abstract][Full Text] [Related]
29. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
[TBL] [Abstract][Full Text] [Related]
30. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
[TBL] [Abstract][Full Text] [Related]
31. Attenuated vesicular stomatitis viruses as vaccine vectors.
Roberts A; Buonocore L; Price R; Forman J; Rose JK
J Virol; 1999 May; 73(5):3723-32. PubMed ID: 10196265
[TBL] [Abstract][Full Text] [Related]
32. Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle.
Mackett M; Yilma T; Rose JK; Moss B
Science; 1985 Jan; 227(4685):433-5. PubMed ID: 2981435
[TBL] [Abstract][Full Text] [Related]
33. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.
Stott EJ; Taylor G; Ball LA; Anderson K; Young KK; King AM; Wertz GW
J Virol; 1987 Dec; 61(12):3855-61. PubMed ID: 3316707
[TBL] [Abstract][Full Text] [Related]
34. Vaccination of mice with replication-defective human immunodeficiency virus induces cellular and humoral immunity and protects against vaccinia virus-gag challenge.
Baliga CS; van Maanen M; Chastain M; Sutton RE
Mol Ther; 2006 Sep; 14(3):432-41. PubMed ID: 16713742
[TBL] [Abstract][Full Text] [Related]
35. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates.
Zhan Y; Deng Y; Huang B; Song Q; Wang W; Yang Y; Dai L; Wang W; Yan J; Gao GF; Tan W
Vaccine; 2019 Apr; 37(15):2122-2130. PubMed ID: 30851967
[TBL] [Abstract][Full Text] [Related]
36. A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector.
Publicover J; Ramsburg E; Rose JK
J Virol; 2005 Nov; 79(21):13231-8. PubMed ID: 16227246
[TBL] [Abstract][Full Text] [Related]
37. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
[TBL] [Abstract][Full Text] [Related]
38. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.
Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S
J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.
Van Rompay KK; Abel K; Earl P; Kozlowski PA; Easlick J; Moore J; Buonocore-Buzzelli L; Schmidt KA; Wilson RL; Simon I; Moss B; Rose N; Rose J; Marthas ML
Vaccine; 2010 Feb; 28(6):1481-92. PubMed ID: 19995539
[TBL] [Abstract][Full Text] [Related]
40. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules.
Eo SK; Gierynska M; Kamar AA; Rouse BT
J Immunol; 2001 May; 166(9):5473-9. PubMed ID: 11313385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
